Doença renal crônica (DRC) is a progressive condition that affects millions of people worldwide. In its late stages, CKD can lead to kidney failure, requiring dialysis or a kidney transplant. Terapia com células-tronco has emerged as a potential treatment option for late-stage CKD, offering hope for patients with this debilitating condition.
Late-Stage Chronic Kidney Disease: An Overview
Late-stage CKD is characterized by a significant decline in kidney function, often leading to a buildup of toxins and fluid in the body. This can cause a range of symptoms, including fatigue, nausea, inchaço, and difficulty concentrating. As the disease progresses, patients may experience kidney failure, requiring dialysis or a kidney transplant to survive.
Terapia com células-tronco: A Potential Treatment Option
Stem cells are unspecialized cells that have the ability to differentiate into various cell types, including kidney cells. Researchers believe that terapia com células-tronco could potentially regenerate damaged kidney tissue and restore kidney function in patients with late-stage CKD.
